Develops and patents technologies for medicines, over-the-counter wellness products and functional fragrances, working with pharmaceutical, food and consumer-goods partners.
10-K for FY2025, filed Mar 11, 2026Impact Biomedical Inc. (“IBO”. “Impact”, “Impact BioMedical”, “we”, “us”, “our” or the “Company”) discovers, confirms, and patents unique…View ↗
By leveraging technology and new science with strategic partnerships, we provide advances in biopharmaceuticals, over the counter direct to…View ↗
3F is a suite of “functional fragrances” containing specialized botanical ingredients (e.g., terpenes) with potential application as an…View ↗
The business model of Impact BioMedical includes licensing and potentially direct sales for commercialization and distribution. Potential…View ↗
Licensing and development partners may pay upfront and option or exercise fees, milestone payments, and royalties on product sales; Celios customers pay when the product ships.
10-K for FY2025, filed Mar 11, 2026
$32K
10-K for FY2025, filed Mar 11, 2026
$32K ↗
Pharmaceutical, food and consumer-goods companies may license technologies or partner on development; the company may also sell directly.
10-K for FY2025, filed Mar 11, 2026The business model of Impact BioMedical includes licensing and potentially direct sales for commercialization and distribution. Potential…View ↗
No. It lost $11.8M in FY2025.
10-K for FY2025, filed Mar 11, 2026
Loading...